Trials / Conditions / X-linked Hypophosphatemia (XLH)
X-linked Hypophosphatemia (XLH)
6 registered clinical trials studyying X-linked Hypophosphatemia (XLH) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Effective Dosing of Burosumab in XLH NCT07183579 | University of Nottingham | — |
| Completed | Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH NCT04842032 | Kyowa Kirin Co., Ltd. | Phase 4 |
| Completed | Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH NCT04842019 | Kyowa Kirin Co., Ltd. | Phase 4 |
| Unknown | Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT NCT04872907 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Y NCT04188964 | Kyowa Kirin Pharmaceutical Development Ltd | Phase 1 / Phase 2 |
| Completed | Retrospective and Prospective Disease Progression and Quality of Life in XLH NCT04049877 | Medialis Ltd. | — |